Tianqi Jiangtang Capsule in the treatment of patients with diabetes: a systematic review and meta-analysis
TJC significantly improves glycemic control in patients with diabetes and shows potential multi-system benefits. However, its efficacy and safety profile require further validation in large-scale, high-quality trials, particularly regarding the influence of genetic factors on treatment response.
Authors
- Yifan Chen (ORCID: https://orcid.org/0009-0002-9183-7860)
- Liuding Wang
- Yixin Liu (ORCID: https://orcid.org/0000-0002-9500-8333)
- Zhonghui Jiang
- Zhuye Gao
Institutions
- Xiyuan Hospital (CN)
- China Academy of Chinese Medical Sciences (CN)
- He Eye Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fphar.2025.1719112
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Academy of Chinese Medical Sciences